Monash IVF flags FY27 profit below $16.1M
Full story: https://grafa.com/en/news/australia/monash-ivf-flags-fy27-profit-below-16-1m
Key points
-
Monash IVF Group stated that its FY27 underlying net profit after tax is expected to fall materially below FY26 and analyst estimates.
-
The company’s share price dropped 20.67% to $0.60 following the trading update.
-
The company is executing a productivity programme targeting $8–$11 million in annualised pre-tax savings to offset rising costs and slower cycle volumes.
Monash IVF Group (ASX:MVF) announced that its FY27 underlying net profit after tax is expected to fall materially below FY26 and consensus estimates, as Australian stimulated-cycle volumes contracted 3.2% in Q1 FY27.
The earnings downgrade follows FY26's underlying net profit after tax of $16.1 million, which had already fallen 41.2% compared to FY25.
"MVF has a strong clinical and scientific platform, and the long-term drivers of demand for fertility care remain compelling," said Monash IVF Group Chair Catherine West.
The company reported that its productivity programme targets $8–$11 million in annualised pre-tax savings, though benefits are expected to realise more slowly than previously anticipated.
Monash IVF stated that it will provide a further trading update when it releases its half-year financial results.
Following the announcement, the Monash IVF Group share price was down at $0.60.
In August, the company launched its Nurture 2030 three-year strategy to cut capital expenditure by 50% and rebuild organic growth.
Recent company moves include appointing Matt Harrington as CFO in October, refreshing its board in August, and expanding its debt facility to $130 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

